Company Analysis

QuidelOrtho Corporation (QDEL)

Nasdaq: QDEL · In Vitro & In Vivo Diagnostic Substances · San Diego, CA · filing with the SEC since 2022
Grade4.8
◀ Past 5.8● Present 5.0▶ Future 3.6

Income statement, as filed

In millions of US dollars (USD), as filed; per-share figures in US dollars; share counts in millions. The fiscal year ends in January.
Income statement, by fiscal year, newest first
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020
Period endingDec 28, 2025Dec 29, 2024Dec 31, 2023Jan 1, 2023Jan 2, 2022Jan 3, 2021
Report filedFeb 19, 2026Feb 27, 2025Feb 29, 2024Feb 23, 2023··
Revenue2,730.22,782.92,997.83,266.01,698.61,661.7
For lenders
Net interest income·-163.5-147.6-75.7-5.8-8.5
Cost of revenue1,456.01,496.41,500.7r1,329.8r420.3305.4
Research and development186.2218.7245.0r187.9r95.784.3
Selling, general and administrative746.3766.8763.2621.0239.6180.7
Operating income-919.2-1,960.9139.1843.7906.01,060.3
Interest expense177.6163.5147.675.7··
Interest and investment income2.22.65.51.30.30.1
Interest income (expense), net-177.6-163.5-147.6-75.7··
Share of profit of equity-method investments2.50.7-3.6-5.81.50.0
Other income (expense), net-5.8-7.1-20.6-8.10.1-1.1
Income before income taxes-1,107.7-2,131.5-29.1735.9900.31,040.3
Income tax expense24.1-79.5-19.0187.2196.1230.0
Net income-1,131.8-2,052.0-10.1548.7704.2810.3
Earnings per share, basic-16.69-30.54-0.159.6616.7419.24
Earnings per share, diluted-16.69-30.54-0.159.5616.4318.60
Weighted average shares, basic67.867.266.856.842.142.1
Weighted average shares, diluted67.867.266.857.442.943.6
As filed with the SEC, each figure from the newest report that carries it, and linked to it. Nothing here is computed.A dot is a line not tagged for that period. r restated by the company in a later report; b a share figure put on the newest basis or filed in the wrong unit. Hover a figure for its filing and note.
What each line is, and the XBRL concept behind it
Revenue what customers paid for what it soldus-gaap:Revenues
Net interest income interest earned less interest paidus-gaap:InterestIncomeExpenseNet
Cost of revenue what it cost to make or buy what it soldus-gaap:CostOfGoodsAndServiceExcludingDepreciationDepletionAndAmortization
Research and development spent on inventing what it sells nextus-gaap:ResearchAndDevelopmentExpense
Selling, general and administrative the cost of selling and of running the companyus-gaap:SellingGeneralAndAdministrativeExpense
Operating income profit from running the business, before interest and taxus-gaap:OperatingIncomeLoss
Interest expense what its borrowing costus-gaap:InterestExpenseNonoperating
Interest and investment income what its cash and investments earnedus-gaap:InterestIncomeOther
Interest income (expense), net interest earned less interest paid, outside the businessus-gaap:InterestIncomeExpenseNonoperatingNet
Share of profit of equity-method investments its share of companies it partly ownsus-gaap:IncomeLossFromEquityMethodInvestments
Other income (expense), net gains and costs outside the businessus-gaap:OtherNonoperatingIncomeExpense
Income before income taxes profit before taxus-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
Income tax expense tax charged on the period's profitus-gaap:IncomeTaxExpenseBenefit
Net income the profit or loss that belongs to the company's shareholdersus-gaap:NetIncomeLoss
Earnings per share, basic net income per share outstandingus-gaap:EarningsPerShareBasic
Earnings per share, diluted net income per share, counting every share that could be issuedus-gaap:EarningsPerShareDiluted
Weighted average shares, basic the average count of shares outstandingus-gaap:WeightedAverageNumberOfSharesOutstandingBasic
Weighted average shares, diluted the average count with every share that could be issuedus-gaap:WeightedAverageNumberOfDilutedSharesOutstanding
SI Assistanton QDEL · research, not advice